Page 6 - அனிதா படேல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moderna Shot Expected to Bolster U.S. Vaccine Efforts © Hans Pennink/Associated Press Health officials across the U.S. are counting on the arrival of a second Covid-19 vaccine to boost scarce supplies and sidestep logistical issues encountered by the first vaccine, which began distribution this week. The U.S. Food and Drug Administration may issue an emergency authorization for a vaccine from Moderna Inc. as early as Friday after an advisory panel recommended the agency approve its use. If authorized, Moderna’s vaccine will join a vaccine from Pfizer Inc. and BioNTech SE that received authorization on Dec. 11. The green light would nearly double this month’s expected U.S. supply of Covid-19 vaccine doses and help meet a federal goal of getting a vaccine to anyone who wants one by the spring or summer of 2021. Moderna expects to add 20 million doses of its vaccine to Pfizer’s expected U.S. supply of 25 million in December.

United statesClaire hannanAnita patelPeter loftusKristen ehresmannCenters for diseaseAssociation of immunization managersHans pennink associatedDrug administrationMinnesota department of healthPfizer incHuman services alex azarModerna incUtah department of healthImmunization managersDisease control